EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries

Davy-Hyacinthe Gouissi Anguechia iD, Yagai Bouba iD, Ezechiel Ngoufack Jagni Semengue, Aude Christelle Ka'e iD, Désiré Takou, Collins Ambe Chenwi iD, Grace Beloumou, Alex Durand Nka, Ulrich Roland Basseck Wome, Maria Mercedes Santoro iD, Francesca Ceccherini-Silberstein, Adawaye Chatté und 8 weitere

Viruses · 2024

DOI: 10.3390/v16121853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Davy-Hyacinthe Gouissi Anguechia und 19 weiteren Autor:innen. Beteiligte Einrichtung: Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Treatment Failure, Drug Resistance, Viral. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management (CIRCB), Collaborative Initiative for Paediatric HIV Education and Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dual therapies (DT) combining integrase strand transfer inhibitors (INSTIs) with second-generation non-nucleoside reverse transcriptase inhibitors (2nd-Gen-NNRTIs) offer new possibilities for HIV treatment to improve adherence. However, drug resistance associated mutations (RAMs) to prior antiretrovirals may jeopardize the efficacy of DT. We herein describe the predicted efficacy of DT combining INSTIs + 2nd-Gen-NNRTI following treatment failure among Cameroonian patients. We genotyped the HIV-1 pol gene using Sanger sequencing and assessed acquired RAMs to NNRTIs and INSTIs in patients failing treatment from March 2019 to December 2023. Drug susceptibility was interpreted using Stanford HIVdb v9.5, and statistical analyses were performed using SPSS v22. Of 130 successfully genotyped participants (median age (IQR): 38 (27–46) years; 59.2% female), 92.3% had RAMs to NNRTIs and 1.5% to INSTIs. Prevailing RAMs were Y181C (32.3%) among NNRTIs and R263K (0.7%) among INSTIs. Among 2nd-Gen-NNRTIs, etravirine, doravirine and rilpivirine had 43.85%, 41.54% and 38.46% genotypic sensitivity, respectively. Among INSTIs, we found 97.69% efficacy for dolutegravir/bictegravir, 96.15% for cabotegravir and 92.31% for elvitegravir/raltegravir. The overall predictive efficacy of DT was lower among participants who failed 1st-Gen-NNRTI (p < 0.001); with etravirine + dolutegravir/bictegravir combination showing the highest score (43.8%). Conclusively, DT combining INSTIs + 2nd-Gen-NNRTIs might be suboptimal in the context of previous ART failure, especially with NNRTI-based treatment in low- and middle-income countries. The general data clearly indicate that without resistance testing, it is nearly impossible to use long-acting dual therapies in previously failing patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsTreatment FailureDrug Resistance, ViralReverse Transcriptase InhibitorsHIV Integrase InhibitorsHeterocyclic Compounds, 3-RingHumansCameroonFemaleAdultMaleMiddle AgedPyridonesGenotypeAnti-HIV AgentsMutationDrug Therapy, CombinationPyridazinesOxazinesHeterocyclic Compounds, 4 or More RingsRilpivirinePyrimidinesDeveloping CountriesAmidesNitrilesPiperazines

Stichwörter der Autor:innen

CameroonHIV-1dual therapiesintegrase strand transfer inhibitornon-nucleosides reverse transcriptase inhibitorspredictive efficacy

Substanzen

Reverse Transcriptase InhibitorsHIV Integrase InhibitorsHeterocyclic Compounds, 3-RingPyridonesAnti-HIV AgentsPyridazinesOxazinesHeterocyclic Compounds, 4 or More RingsRilpivirinePyrimidines

Autor:innen und Institutionen

  • Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé P.O. Box 3077, Cameroon.
  • Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé P.O. Box 337, Cameroon.
  • Faculty of Medicine, UniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy.
  • National HIV Drug Resistance Working Group, Yaoundé P.O. Box 1459, Cameroon.
  • Department of Experimental Medicine, University of Rome "Tor Vergata", 00133 Rome, Italy.
  • Project Management Unit, Ministry of Health, N'djamena P.O. Box 548, Chad.

ORCID-Profile: Davy-Hyacinthe Gouissi Anguechia, Yagai Bouba, Aude Christelle Ka'e, Collins Ambe Chenwi, Maria Mercedes Santoro, Giulia Cappelli, Joseph Fokam

Förderung

  • Chantal BIYA International Reference Centre for research on HIV/AIDS prevention and management (CIRCB)
  • Collaborative Initiative for Paediatric HIV Education and Research

Zitieren

APA

Gouissi Anguechia, D. H., Bouba, Y., Semengue, E. N. J., Ka'e, A. C., Takou, D., Ambe Chenwi, C., Beloumou, G., Nka, A. D., Basseck Wome, U. R., Santoro, M. M., Ceccherini-Silberstein, F., Chatté, A., Montesano, C., Cappelli, G., Colizzi, V., Ndjolo, A., Mbanya, D., Ndembi, N., Perno, C. F., & Fokam, J. (2024). Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries. Viruses. https://doi.org/10.3390/v16121853

Vancouver

Gouissi Anguechia DH, Bouba Y, Semengue ENJ, Ka'e AC, Takou D, Ambe Chenwi C, et al. Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries. Viruses. 2024. doi:10.3390/v16121853

BibTeX
@article{GouissiAnguechia2024,
  author = {Gouissi Anguechia, Davy-Hyacinthe and Bouba, Yagai and Semengue, Ezechiel Ngoufack Jagni and Ka'e, Aude Christelle and Takou, Désiré and Ambe Chenwi, Collins and Beloumou, Grace and Nka, Alex Durand and Basseck Wome, Ulrich Roland and Santoro, Maria Mercedes and Ceccherini-Silberstein, Francesca and Chatté, Adawaye and Montesano, Carla and Cappelli, Giulia and Colizzi, Vittorio and Ndjolo, Alexis and Mbanya, Dora and Ndembi, Nicaise and Perno, Carlo-Federico and Fokam, Joseph},
  title = {Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16121853}
}
Kostenlos starten →